Pharmbio Korea Co Ltd - Company Review
Pharmbio Korea Co Ltd - Company ReviewSummary
Pharmbio Korea Co Ltd (Pharmbio) is a drug company that manufactures and markets various pharma products for various therapeutic areas. The company offers products in therapeutic areas such as urology, gastroenterology, pediatrics, pain control, orthopedics and OB/GY; cardiovascular and oncology products. Its urology products comprise urocitra, someto, peyron, lura-xl and tamstar products, among others. Pharmbio’s cardiovascular products include telcatan plus and telcatan. The company provides products in dosage forms such as solutions, powders and tablets. It markets its products through its network of distributors. Pharmbio is headquartered in Seoul, South Korea.
This comprehensive company report of Pharmbio Korea Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.